🇺🇸 FDA

Company profile · Sponsor

Neumora

Neumora Therapeutics

NMRA · NYSE biotech WATERTOWN, MA, USA
Pipeline
5
Drugs
0
Patents
6

Quick answer

Neumora (NMRA) is a biotech company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 6 patents to this profile..

Company facts

Ticker NMRA
Exchange NYSE
Company type biotech
Headquarters WATERTOWN, MA, USA
SEC CIK 0001885522

Pipeline (5)

Search pipeline →

  1. NMRA-335140

    Neumora

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  2. NMRA-335140

    Neumora

    Major Depressive Disorder

    phase 3 small molecule active

    5 trials

  3. Placebo is identical to the active NMRA-335140 but without the active drug substance to maintain study blinding., NMRA-335140

    Neumora

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  4. NMRA-335140 80 mg

    Neumora

    Major Depressive Episode Associated With Bipolar II Disorder

    phase 2 small molecule completed

    1 trial

  5. NMRA-323511

    Neumora

    Alzheimer's Disease

    phase 1 small molecule completed

    1 trial

Patents (6)

Search patents →

  1. US 12371414

    Methods of treating neurological disorders

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12247037

    1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12171758

    Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12152038

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11993580

    Methods of treating neurological disorders

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11858943

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Neumora?

Neumora (NMRA) is a biotech company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 6 patents to this profile..

What pipeline programs does Neumora sponsor?

We track 5 ClinicalTrials.gov-linked programs for Neumora, including NMRA-335140 and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Neumora company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.